A single injection of the drug lepodisiran slashed a key heart risk factor, lipoprotein(a), by 94% for six months, offers hope for treating a genetic cause of heart disease.
Get all latest & breaking news on Gilead Sciences. Watch videos, top stories and articles on Gilead Sciences at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results